Your English writing platform
Discover LudwigSuggestions(5)
Exact(14)
At an average follow-up of 7.1 years, no significant differences of FB over MB design could be demonstrated with respect to the American Knee Society score (AKSS), pain score, a questionnaire of general health (SF-12 score), range of motion (ROM), or complication rates.
By grouping age of patients by tertiles (<45 years, 45 to 59 years, >60 years), no significant differences in outcomes based on age were found (0.3894).
A total of 23 PD patients (mean age = 64.02±5.47 years, 10 females, mean duration since first diagnosis = 6.33±3.93 years) and 18 healthy controls (mean age = 62.17±5.40 years, no significant differences with the PD group, 10 females) were evaluated.
In 24 patients aged ⩾70 years, no significant differences in efficacy or safety outcomes were found.
In both years, no significant differences were observed in relative chlorophyll content at 20 25 days after anthesis (DAA).
Also in long-term follow-up (up to eleven years), no significant differences between groups were observed based on CT assessment [ 50].
Similar(46)
According to the different age groups such as <50, 50 64, 65 74 and 75⩽ years, no significant difference was found among the age groups in the 1990 2000 cohort.
After 2 years, no significant difference was found in the cumulative survival rates of the two types of restoration.
The majority of both groups had an education level between 8 and 12 years (no significant difference).
At three years, no significant difference was noted between the donepezil-treated group and the placebo-treated group in rates of institutionalization or progression of disability.
The average age at start of work as an office-based physician was similar in both groups (37.3 vs. 38.3 years, no significant difference).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com